SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Galapagos Islands -- Ignore unavailable to you. Want to Upgrade?

To: Nancy who wrote (6779)10/14/2002 11:15:55 PM
From: Jorj X Mckie  Read Replies (1) | Respond to of 57110
 
woohoo! bear market is over....



To: Nancy who wrote (6779)10/15/2002 4:09:33 PM
From: Jorj X Mckie  Respond to of 57110
 
16:07 ET MLNM Millennium Pharm misses by four cents (10.00 +0.30)
Reports Q3 (Sep) loss of $0.31 per share, $0.04 worse than the Multex consensus of ($0.27); revenues rose 16.5% year/year to $95.8 mln vs the $97.5 mln consensus; Integrilin sales growth guidance "remains unchanged at $300 million in worldwide sales for 2002, of which Millennium expects to record approximately $150 million in revenue."


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News